Alka Laboratories Profile
Key Indicators
- Authorised Capital ₹ 32.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 28.08 Cr
as on 16-11-2024
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 27.30 Cr
as on 16-11-2024
- Satisfied Charges ₹ 39.13 Cr
as on 16-11-2024
- Revenue 22.45%
(FY 2023)
- Profit -1687.41%
(FY 2023)
- Ebitda -182.37%
(FY 2023)
- Net Worth 50.78%
(FY 2023)
- Total Assets -5.63%
(FY 2023)
About Alka Laboratories
The Corporate was formerly known as Alka Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 32.50 Cr and a paid-up capital of Rs 28.08 Cr.
The company currently has active open charges totaling ₹27.30 Cr. The company has closed loans amounting to ₹39.13 Cr, as per Ministry of Corporate Affairs (MCA) records.
Deepak Gupta, Ankur Gupta, and Sanjay Tiwari serve as directors at the Company.
- CIN/LLPIN
U24200DL1998PTC379814
- Company No.
114840
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Alka Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Gupta  | Director | 16-Dec-2020 | Current |
| Ankur Gupta | Director | 09-Nov-2020 | Current |
| Sanjay Tiwari | Director | 30-Jan-2021 | Current |
Financial Performance of Alka Laboratories.
Alka Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.45% increase. The company also saw a substantial fall in profitability, with a 1687.41% decrease in profit. The company's net worth Soared by an impressive increase of 50.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alka Laboratories?
In 2023, Alka Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bharat Pet Products Private LimitedActive 14 years 11 monthsDeepak Gupta and Ankur Gupta are mutual person
- Bpl Lifescience Private LimitedActive 5 years 2 months
Deepak Gupta and Ankur Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Dec 2021 | ₹9.95 M | Open |
Others Creation Date: 04 Mar 2021 | ₹26.30 Cr | Open |
Others Creation Date: 17 Apr 2018 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Alka Laboratories?
Alka Laboratories has a workforce of 94 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alka Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alka Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
